Pro-chondrogenic gene expression

"Pro-chondrogenic gene expression" refers to the coordinated upregulation of genes essential for chondrogenesis—the process by which cartilage is formed from precursor cells[2][1][3]. This includes transcription factors such as **SOX9**, **NKX3.2**, and **PAX9**, as well as key extracellular matrix proteins like **COL2A1** and **Aggrecan**. The induction of this gene program is regulated by signaling molecules (e.g., TGF-β, BMPs), transcriptional regulators (e.g., SOX9, HIF1a), and biomechanical cues (including those transduced through YAP/TAZ and RhoA/ROCK pathways)[1][2][3][5]. While modulation of pro-chondrogenic gene expression is a major goal in regenerative medicine and tissue engineering for cartilage repair, the term itself does not denote a druggable target, but rather a desired functional state induced by manipulating upstream pathways or providing specific environmental cues. Because "pro-chondrogenic gene expression" describes a biological process rather than a discrete molecular entity, it is not recognized as a canonical therapeutic target, and its use as such is incorrect in the context of structured drug target databases.

Other names

Chondrogenic gene expressionChondrogenic programCartilage differentiation gene program